Nebula Research & Development LLC Spring Works Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 6,892 shares of SWTX stock, worth $243,632. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,892Holding current value
$243,632% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
221Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$231 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$199 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$131 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$127 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$121 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.21B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...